Back
Arcturus Therapeutics Holdings Stock Predictions
Sponsored
ARCT
Sponsored
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Sell
35
ARCT
Arcturus Therapeutics Holdings
Last Price:
26.53
Seasonality Move:
34.84%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the cornerArcturus Therapeutics Holdings Stock Forecast
- Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 8.5% based on the past 10 years of stock performance.
- Arcturus Therapeutics Holdings has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Arcturus Therapeutics Holdings Stock Undervalued?
The current Arcturus Therapeutics Holdings [ARCT] share price is $26.55. The Score for ARCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal. - ARCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Arcturus Therapeutics Holdings Stock Go Up Next Year?
- Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 8.5% based on the past 10 years of stock performance.
Arcturus Therapeutics Holdings Stock Rating
Sell
35
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings overpriced?
- Arcturus Therapeutics Holdings has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Arcturus Therapeutics Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com
52-Week Data
52-Week High:
43.81
52-Week Low:
17.52
Prediction Charts
Market Cap:
714.6M
Price in USD:
26.55
Volume:
272.39K
Beta:
2.48
Technical Analysis
SMA50:
33.82
SMA100:
32.86
SMA200:
29.92
52-Wk Change:
-0.38%
Stock Predictions
-
Is Arcturus Therapeutics Holdings stock public?
Yes, Arcturus Therapeutics Holdings is a publicly traded company. -
What is the Arcturus Therapeutics Holdings stock quote today?
The Arcturus Therapeutics Holdings stock price is 26.55 USD today. -
How to buy Arcturus Therapeutics Holdings stock online?
You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-9 | 30.83 | 31.70 | 31.71 | 30.30 |
Apr-10 | 30.46 | 31.85 | 31.94 | 30.14 |
Apr-11 | 32.32 | 32.54 | 33.11 | 31.86 |
Apr-12 | 32.28 | 30.48 | 32.30 | 30.02 |
Apr-15 | 30.57 | 29.31 | 30.68 | 29.08 |
Apr-16 | 29.06 | 30.13 | 30.76 | 28.79 |
Apr-17 | 30.25 | 27.67 | 30.89 | 27.47 |
Apr-18 | 27.14 | 26.33 | 27.45 | 26.26 |
Apr-19 | 26.06 | 25.98 | 26.88 | 25.57 |
Apr-22 | 26.17 | 27.06 | 27.74 | 25.96 |
Apr-23 | 27.03 | 27.93 | 28.80 | 27.03 |
Apr-24 | 28.20 | 26.98 | 28.38 | 26.59 |
Apr-25 | 26.09 | 26.17 | 26.80 | 25.41 |
Apr-26 | 26.28 | 26.55 | 26.86 | 25.84 |
Arcturus Therapeutics Holdings Earnings
Arcturus Therapeutics Holdings Earnings Report: Per Share Arcturus Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcturus Therapeutics Holdings Forecast Revenue Growth
Arcturus Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.20 per share, an increase next quarter of $1.92 per share, an increase this year of $0.03 per share, and an increase next year of $2.89 per share.
* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.